July 16, 2020 Clinical Research/Diagn. Licensing, IP, and Legal Life Science Tools Liq. Handling & Robotics

Promega Maxwell® RNA Extraction System Authorized for Use in CDC COVID-19 Emergency Use Authorization (EUA) Diagnostic Panel

Promega automated sample preparation solution added to CDC COVID-19 test protocol Madison, WI USA. (July 16, 2020) Promega Corporation Maxwell® RSC 48 Instrument and Maxwell® RSC Viral Total Nucleic Acid Purification Kit (Maxwell® Extraction System) are now in the Centers for Disease Control and Prevention’s (CDC) COVID-19 diagnostic protocol for emergency use. In a letter dated July... Read more

July 13, 2020 Clinical Research/Diagn. Lab Top-10 Life Science Tools M&A, Partnerships

Thermo Fisher Scientific and First Genetics JCS Partner to Develop Next-Generation Sequencing-Based Diagnostics in Russia

Thermo Fisher Scientific and First Genetics JCS Partner to Develop Next-Generation Sequencing-Based Diagnostics in Russia CARLSBAD, Calif., July 13, 2020 /PRNewswire/ — Thermo Fisher Scientific and First Genetics JCS, a manufacturer of diagnostic equipment and IVD kits intended to advance molecular genetic technologies into clinical practice, today announced a strategic partnership focused on commercializing next-generation sequencing... Read more

July 8, 2020 Bio/Pharma/CRO Clinical Research/Diagn. Lab Top-10 M&A, Partnerships

Thermo Fisher Scientific Signs Companion Diagnostic Agreement with Chugai Pharmaceutical

Thermo Fisher Scientific Signs Companion Diagnostic Agreement with Chugai Pharmaceutical Agreement aims to expedite local biomarker testing of NSCLC patients eligible for entrectinib in Japan CARLSBAD, Calif., July 8, 2020 /PRNewswire/ — Thermo Fisher Scientific has signed a companion diagnostic (CDx) agreement with Chugai Pharmaceutical Co., Ltd., a member of the Roche Group, and has applied... Read more

June 11, 2020 Clinical Research/Diagn. Life Science Tools M&A, Partnerships

Zymo Research Collaborates With Companies to Support COVID-19 Testing

CALIFORNIA COMPANIES WORK TOGETHER TO MAKE NEW EUA COVID-19 TESTS AVAILABLE IRVINE, Calif., (June 11, 2020) — With the support of Zymo Research products, two California-based companies, Fulgent Genetics located in Temple City and Curative Inc. based in Menlo Park, have received Emergency Use Authorizations from the US Food and Drug Administration for their rRT-PCR tests... Read more

June 11, 2020 Clinical Research/Diagn. Life Science Tools Product Launch

PCR Biosystems launches 4x RT-qPCR kit to enable ultra-sensitive, high-throughput detection of viral RNA sequences

Caption: New qPCRBIO Probe 1-Step Virus Detect. Click images to download. London, UK (11 June 2020) – PCR Biosystems, the UK-based PCR experts, today announced the launch of qPCRBIO Probe 1-Step Virus Detect, a high-concentration 4x RT-qPCR kit designed specifically for ultra-sensitive, high-throughput detection of viral RNA sequences, including SARS-CoV-2. The new kit, which marks the latest... Read more

June 10, 2020 Acad, Gov/Utilities Clinical Research/Diagn. Environ, Ag./Food & Bev Life Science Tools PR/Corporate

Illumina Receives First FDA Emergency Use Authorization for a Sequencing-Based COVID-19 Diagnostic Test

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) is paving the way for large-scale, next-generation sequencing-based (NGS) COVID-19 testing. Today, the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for the Illumina COVIDSeq™ Test, a high-throughput, sequencing-based, in vitro diagnostic (IVD) workflow enabling the detection of SARS-CoV-2. The end-to-end workflow extends the options... Read more

June 9, 2020 Clinical Research/Diagn. M&A, Partnerships

Bio-Techne and Zero – The End of Prostate Cancer Announce Partnership to Fund Education and Awareness Campaigns to Empower Men With Prostate Cancer

MINNEAPOLIS, June 11, 2020 /PRNewswire/ — Bio-Techne Corporation (NASDAQ:TECH) today announced that Exosome Diagnostics, a Bio-Techne brand, has established a new partnership with ZERO – The End of Prostate Cancer, the leading national nonprofit organization in the fight against prostate cancer. ZERO advances research, improves the lives of men and families, and inspires action for patients,... Read more

June 9, 2020 Clinical Research/Diagn. Licensing, IP, and Legal

Promega Microsatellite Instability Molecular Test, OncoMate™ MSI Dx Analysis System, CE Marked and Available in Europe

New diagnostic test for MSI in solid tumors can inform physicians on immuno-oncology therapies and can guide treatment decisions for patients with Lynch-associated cancers Leiden, Netherlands and Madison, WI USA. (June 9, 2020) Promega Corporation today announced CE marking for the OncoMate™ MSI Dx Analysis System(OncoMate™ MSI) as a new in vitro diagnostic (IVD) medical device in Europe.... Read more